Combination chemotherapy.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000096:biosynthesis; D004261:DNA Replication / Q000187:drug effects; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007700:Kinetics; D008466:Mechlorethamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013329:Structure-Activity Relationship; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D004317:Doxorubicin; D004247:DNA; D011241:Prednisone; D003630:Daunorubicin